BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

863 related articles for article (PubMed ID: 21805576)

  • 1. Clinical outcome of transcatheter aortic valve implantation in patients with low-flow, low gradient aortic stenosis.
    Gotzmann M; Lindstaedt M; Bojara W; Ewers A; Mügge A
    Catheter Cardiovasc Interv; 2012 Apr; 79(5):693-701. PubMed ID: 21805576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcome following Transcatheter Aortic Valve Implantation in patients with impaired left ventricular systolic function.
    van der Boon RM; Nuis RJ; Van Mieghem NM; Benitez LM; van Geuns RJ; Galema TW; van Domburg RT; Geleijnse ML; Dager A; de Jaegere PP
    Catheter Cardiovasc Interv; 2012 Apr; 79(5):702-10. PubMed ID: 22121094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcatheter aortic valve implantation for paradoxical low-flow low-gradient aortic stenosis patients.
    Debry N; Sudre A; Amr G; Delhaye C; Schurtz G; Montaigne D; Koussa M; Modine T
    Catheter Cardiovasc Interv; 2016 Mar; 87(4):797-804. PubMed ID: 26424679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes of patients with low-flow, low-gradient, severe aortic stenosis and either preserved or reduced ejection fraction undergoing transcatheter aortic valve implantation.
    O'Sullivan CJ; Stortecky S; Heg D; Pilgrim T; Hosek N; Buellesfeld L; Khattab AA; Nietlispach F; Moschovitis A; Zanchin T; Meier B; Windecker S; Wenaweser P
    Eur Heart J; 2013 Nov; 34(44):3437-50. PubMed ID: 24096324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Transcatheter aortic valve implantation (TAVI)TAVI): A new therapeutic option for patients with severe symptomatic aortic stenosis who are not suitable or at high risk for surgical valve replacement].
    Zahn R; Schiele R; Kilkowski C; Klein B; Schwarz AK; Zeymer U; Lehmann A; Cornelius B; Horack M; Saggau W; Werling C
    Dtsch Med Wochenschr; 2010 Aug; 135(33):1589-95. PubMed ID: 20717862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular global systolic longitudinal deformation and prognosis 1 year after femoral and apical transcatheter aortic valve implantation.
    Løgstrup BB; Andersen HR; Thuesen L; Christiansen EH; Terp K; Klaaborg KE; Poulsen SH
    J Am Soc Echocardiogr; 2013 Mar; 26(3):246-54. PubMed ID: 23306032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of mitral regurgitation on clinical outcomes of patients with low-ejection fraction, low-gradient severe aortic stenosis undergoing transcatheter aortic valve implantation.
    O'Sullivan CJ; Stortecky S; Bütikofer A; Heg D; Zanchin T; Huber C; Pilgrim T; Praz F; Buellesfeld L; Khattab AA; Blöchlinger S; Carrel T; Meier B; Zbinden S; Wenaweser P; Windecker S
    Circ Cardiovasc Interv; 2015 Feb; 8(2):e001895. PubMed ID: 25657315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular functional recovery and remodeling in low-flow low-gradient severe aortic stenosis after transcatheter aortic valve implantation.
    Kamperidis V; Joyce E; Debonnaire P; Katsanos S; van Rosendael PJ; van der Kley F; Sianos G; Bax JJ; Ajmone Marsan N; Delgado V
    J Am Soc Echocardiogr; 2014 Aug; 27(8):817-25. PubMed ID: 24906801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical presentation and outcomes after transcatheter aortic valve implantation in patients with low flow/low gradient severe aortic stenosis.
    Elhmidi Y; Piazza N; Krane M; Deutsch MA; Mazzitelli D; Lange R; Bleiziffer S
    Catheter Cardiovasc Interv; 2014 Aug; 84(2):283-90. PubMed ID: 24407885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart failure in severe aortic valve stenosis: prognostic impact of left ventricular ejection fraction and mean gradient on outcome after transcatheter aortic valve implantation.
    Gotzmann M; Rahlmann P; Hehnen T; Müller P; Lindstaedt M; Mügge A; Ewers A
    Eur J Heart Fail; 2012 Oct; 14(10):1155-62. PubMed ID: 22782969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of low flow on the outcome of high-risk patients undergoing transcatheter aortic valve replacement.
    Le Ven F; Freeman M; Webb J; Clavel MA; Wheeler M; Dumont É; Thompson C; De Larochellière R; Moss R; Doyle D; Ribeiro HB; Urena M; Nombela-Franco L; Rodés-Cabau J; Pibarot P
    J Am Coll Cardiol; 2013 Aug; 62(9):782-8. PubMed ID: 23770162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of outcomes in low-flow, low-gradient aortic stenosis: results of the multicenter TOPAS Study.
    Clavel MA; Fuchs C; Burwash IG; Mundigler G; Dumesnil JG; Baumgartner H; Bergler-Klein J; Beanlands RS; Mathieu P; Magne J; Pibarot P
    Circulation; 2008 Sep; 118(14 Suppl):S234-42. PubMed ID: 18824760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcatheter aortic valve implantation with a self-expanding nitinol bioprosthesis: prediction of the need for permanent pacemaker using simple baseline and procedural characteristics.
    Saia F; Lemos PA; Bordoni B; Cervi E; Boriani G; Ciuca C; Taglieri N; Mariani J; Kalil Filho R; Marzocchi A
    Catheter Cardiovasc Interv; 2012 Apr; 79(5):712-9. PubMed ID: 22109957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transapical aortic valve implantation in patients with previous cardiac surgery.
    Papadopoulos N; Ilioska P; Fichtlscherer S; Lehmann R; Beiras Fernandez A; Moritz A; Doss M; Zierer A
    Ann Thorac Surg; 2014 Jan; 97(1):37-42. PubMed ID: 24075497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of severe left ventricular systolic dysfunction on hospital outcome after transcatheter aortic valve implantation or surgical aortic valve replacement: results from a propensity-matched population of the Italian OBSERVANT multicenter study.
    Onorati F; D'Errigo P; Grossi C; Barbanti M; Ranucci M; Covello DR; Rosato S; Maraschini A; Santoro G; Tamburino C; Seccareccia F; Santini F; Menicanti L;
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):568-75. PubMed ID: 24263007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between transcatheter and surgical prosthetic valve implantation in patients with severe aortic stenosis and reduced left ventricular ejection fraction.
    Clavel MA; Webb JG; Rodés-Cabau J; Masson JB; Dumont E; De Larochellière R; Doyle D; Bergeron S; Baumgartner H; Burwash IG; Dumesnil JG; Mundigler G; Moss R; Kempny A; Bagur R; Bergler-Klein J; Gurvitch R; Mathieu P; Pibarot P
    Circulation; 2010 Nov; 122(19):1928-36. PubMed ID: 20975002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term Doppler hemodynamics and effective orifice areas of Edwards SAPIEN and medtronic CoreValve prostheses after TAVI.
    Spethmann S; Dreger H; Baldenhofer G; Pflug E; Sanad W; Stangl V; Baumann G; Grubitzsch H; Sander M; Stangl K; Laule M; Knebel F
    Echocardiography; 2014 Mar; 31(3):302-10. PubMed ID: 24111700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Year Outcomes After Transcatheter Aortic Valve Implantation With CoreValve Prosthesis.
    Barbanti M; Petronio AS; Ettori F; Latib A; Bedogni F; De Marco F; Poli A; Boschetti C; De Carlo M; Fiorina C; Colombo A; Brambilla N; Bruschi G; Martina P; Pandolfi C; Giannini C; Curello S; Sgroi C; Gulino S; Patanè M; Ohno Y; Tamburino C; Attizzani GF; Immè S; Gentili A; Tamburino C
    JACC Cardiovasc Interv; 2015 Jul; 8(8):1084-1091. PubMed ID: 26117458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcatheter aortic valve implantation by the left axillary approach: a single-center experience.
    Laflamme M; Mazine A; Demers P; Lamarche Y; Ibrahim R; Asgar A; Cartier R
    Ann Thorac Surg; 2014 May; 97(5):1549-54. PubMed ID: 24462415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early hemodynamic and neurohormonal response after transcatheter aortic valve implantation.
    Sherif MA; Abdel-Wahab M; Awad O; Geist V; El-Shahed G; Semmler R; Tawfik M; Khattab AA; Richardt D; Richardt G; Tölg R
    Am Heart J; 2010 Nov; 160(5):862-9. PubMed ID: 21095273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.